Home › Neurologic Diseases › New York
Neurologic Diseases clinical trials in New York
8 studies for Neurologic Diseases are looking for participants at sites in New York.
Cities in New York
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, New York
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 30, 2026 · NCT06887192Product Surveillance Registry
- Albany
- Bay Shore
- Huntington
- and 10 more
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #055, Amherst
- Vima Site #024, New York
- Vima Site #052, Patchogue
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 11, 2026 · NCT07804615A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, New York
- Clinical Site, Staten Island
- Clinical Site, The Bronx
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)
- Icahn School of Medicine at Mount Sinai, New York
RecruitingObservational study
7 Months – 15 Months · All sexes · Updated Aug 31, 2026 · NCT06805695Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
- University of Rochester Center for Health and Technology (CHeT), Rochester
Recruiting
Ages 50 and older · All sexes · Updated Aug 27, 2026 · NCT06993142INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study
- University of Buffalo Neurosurgery, Buffalo
- Mount Sinai Hospital, New York
Recruiting
Ages 22 and older · All sexes · Updated May 11, 2026 · NCT07543367Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Staten Island
RecruitingPhase 2
Ages 50 to 85 · All sexes · Updated Feb 2, 2026 · NCT07105709From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.